Women's Health Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly


We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Breast Camcer

First patients enrolled in three breast cancer studies for Modrenal

These studies are investigating the efficacy of Modrenal in three distinct settings:

1) a phase IV trial in advanced, postmenopausal breast cancer,

2) a phase II trial in premenopausal breast cancer; and

3) a phase II trial utilizing Modrenal as a neoadjuvant treatment in postmenopausal breast cancer.

The phase IV study will evaluate the efficacy of Modrenal in postmenopausal women who have failed prior aromatase inhibitor therapy. The...

• View Other Issues of Women's Health Weekly
  
• View Other NewsRx Publications